Blog
The Evidence Ladder: How to Read Peptide Research Without Being Fooled
Peptides attract strong claims, and the claims often rest on a single study that sounds more impressive than it is. A simple mental model, the evidence ladder, helps place any result in proportion.
Key takeaways
- Evidence rises from lab models to animals to human trials to reviews of many trials.
- Each step up reduces the chance of being misled.
- Animal results often fail to translate to humans.
- Red flags include tiny samples, no controls and a single research group.
The rungs
- Rung 1: in silico and in vitro. Computer models, purified proteins and cell cultures. Fast and cheap, good for mechanism, weak for predicting whole-body effects.
- Rung 2: animal studies. Whole-organism physiology. Informative but limited by species differences, dosing and often small groups.
- Rung 3: human observational data. Case reports and cohort studies. They can generate ideas but struggle with confounding.
- Rung 4: randomized controlled trials. Random assignment, controls and blinding. The strongest single type of evidence for effects in people.
- Rung 5: systematic reviews and meta-analyses. Combine many trials and weigh their quality.
A real-world example
For BPC-157, a large share of the published literature comes from a small number of research groups, mostly working in rodents, and the human trial evidence is thin. That does not mean the findings are wrong. It means the evidence sits on a lower rung, and replication by independent laboratories carries a lot of weight. Our summary in BPC-157 research: what the current studies actually show goes through the details.
Why animal results often do not transfer
- Species biology differs, including receptors, metabolism and immune systems.
- Dose scaling is not linear. Conversions between species commonly use body surface area, and still carry large uncertainty.
- Animal models mimic conditions imperfectly, such as an acute injury in a young, healthy animal versus chronic disease in older people.
- Publication bias favors positive results, so failed studies are underrepresented.
Red flags
- No control group, or a control that did not match the vehicle and handling.
- Very small groups, such as 3 to 5 animals per arm, without a power calculation.
- Outcomes that were not predefined, found by looking at many measures and highlighting the ones that moved.
- Only one laboratory reporting all the results.
- Sweeping conclusions in the abstract not supported by the data.
- Commercial funding without disclosure.
Green flags
- Preregistered outcomes and analysis plan.
- Blinded outcome assessment and randomization.
- Independent replication.
- Raw data or methods available.
- Honest limitations section.
Where research-grade material fits
Reading a paper well also means asking what material was used. Studies that characterize their compounds with purity and identity data are easier to trust and reproduce. Compounds sold for research are not drugs, as explained in research-grade versus pharmaceutical-grade.
The bottom line
Ask which rung a claim sits on, and who else has repeated it. If the answer is a mouse and one lab, the claim is an interesting lead, not a conclusion.
Related reading
- Vehicle, Scrambled and Positive Controls in Peptide Studies
- BPC-157 Research: What the Current Studies Actually Show
- Research-Grade vs. Pharmaceutical-Grade: What the Peptide Label Differences Actually Mean
- Browse the full Research Library
For laboratory research use only. Not for human or veterinary use, and not intended to diagnose, treat, cure or prevent any condition. This article is educational and is not medical advice.